What is the clinical and cost-effectiveness of C-reactive protein point-of-care testing to guide antibiotic prescribing in patients presenting to primary care with symptoms of lower respiratory tract infection?
Healthcare Improvement Scotland.
Scottish Health Technologies Group.
"This plain language summary has been produced based on SHTG advice statement 008-18 May 2018"
System requirements: Adobe Reader required to view PDF document.
Description from online resource; title from PDF caption title (Healthcare Improvement Scotland, viewed 3 May, 2019)
C-reactive protein
Drugs
Antibiotics.
Respiratory infections